Jim Pearce is the Chief Investment Strategist of Personal Finance, our flagship publication, and serves as Director of the Investing Daily Wealth Society. He is also the Director of Research at Investing Daily, overseeing the work of our entire analyst team. He began his career as a stockbroker in 1983 and over the years has managed client investment portfolios for major banks, brokerage firms and investment advisors. Jim has a BA in Business Management from The College of William & Mary, and a CFP from the College for Financial Planning.
When compiling a list of the best coffee stocks to own, Starbucks (NSDQ: SBUX) is usually the first name that comes to mind. And for good reason; Starbucks is the largest publicly traded coffee retailer in the world. With a market value of $80 billion and one of its ubiquitous… Read More
Uranium is one of the most specialized chemical elements on the planet. Its commercial use is limited to fueling power plants and making weapons. The best uranium stocks to buy now are those that have an inside track on those markets. The nuclear energy sector has undergone considerable change during… Read More
Tata Motors (NYSE: TTM) is making good on its promise to cut costs to improve profitability. Yesterday, Tata Motors announced that it is eliminating 4,500 jobs in its Jaguar Land Rover division in Europe. Its share price jumped 1% on the news, trading… Read More
If you’re following traditional retirement advice that made sense 50 years ago, you may be missing out on the most effective retirement strategy today. Financial Planners hate it. But there’s no denying that thousands of Americans are retiring decades early using a novel 6-step retirement approach. According to Money Magazine,… Read More
The Washington Post recently reported, “An early retirement is doable. Here’s how.” One 56-year-old Larry T., who took the challenge, claims, “I woke up one day and said that was it.” Thousands of Americans are taking The 1-Minute Retirement Challenge and discovering they can retire more than a decade early. Read More
Shares of healthcare conglomerate Johnson & Johnson (NYSE: JNJ) plunged 10% on December 14 in response to an investigative news story by Reuters that accused the company of covering up the use of asbestos in its popular baby powder product: “From at least 1971 to the early 2000s,… Read More
The stock market’s steep drop at the end of 2018 is good news for value investors. The list of candidates for best stocks under 20 dollars in 2019 just got longer as a result. Even still, just because a stock is cheap doesn’t mean it’s a bargain. Only 5% of… Read More